Ascorbic acidAcute oxalate nephropathy due to off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1830卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86014-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：64 / 64

相关论文

共 50 条

[31] EverolimusPneumonitis and off label use: case report
Reactions Weekly, 2019, 1750 (1) : 122 - 122
[32] TemozolomideNeutropenia and off label use: case report
Reactions Weekly, 2020, 1789 (1) : 252 - 252
[33] CotrimoxazoleHyperkalaemia and off label use: case report
Reactions Weekly, 2022, 1909 (1) : 194 - 194
[34] SorafenibNeutropenia and off label use: case report
Reactions Weekly, 2022, 1927 (1) : 482 - 482
[35] TeriparatideHypercalciuria and off label use: case report
Reactions Weekly, 2022, 1919 (1) : 561 - 561
[36] DexamethasoneOsteonecrosis and off label use: case report
Reactions Weekly, 2022, 1922 (1) : 216 - 216
[37] RituximabHypogammaglobulinaemia and off label use: case report
Reactions Weekly, 2023, 1948 (1) : 381 - 381
[38] Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms
Weijie Violet Lin
Christie Gloria Turin
David Walter McCormick
Christopher Haas
Gregory Constantine
CEN Case Reports, 2019, 8 : 67 - 70
[39] Ascorbic acid-induced oxalate nephropathy: a case report and discussion of pathologic mechanisms
Lin, Weijie Violet
Turin, Christie Gloria
McCormick, David Walter
Haas, Christopher
Constantine, Gregory
CEN CASE REPORTS, 2019, 8 (01) : 67 - 70
[40] DexamethasoneCandida albicans endogenous endophthalmitis due to off-label use: case report
Reactions Weekly, 2022, 1908 (1) : 202 - 202

← 1 2 3 4 5 →